Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study
< Back to Find a Trial

A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer’s Disease (M15-566)

ID
NCT02880956
Condition Studied
Alzheimer's Disease
Phase
Phase II
Status
Closed
Intervention
ABBV-8E12
Principal Investigator
Sponsor
AbbVie

Please go to ClinicalTrials.gov for more information.